How Does Tabelecleucel Work? A Guide to EBV-Specific T-Cell Immunotherapy
•
3 min read
Clinical trials show that tabelecleucel can achieve objective response rates of over 50% in patients with relapsed or refractory EBV+ PTLD. For those with this aggressive disease, understanding **how does tabelecleucel work** reveals a targeted approach using donor T-cells to specifically eliminate EBV-infected cells that drive the condition.
